MoneyWorks4Me

The Total revenue for the quarter ended December 2023 of  Rs. 1328.30 millions remain, more or less, the same.The Company's Net profit for the December 2023 quarter have declined marginally to Rs. 554.50  millions as against Rs. 591.70 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 812.20 millions from 808.70 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1328.30 1306.00 1.71 4857.10 3839.40 26.51 5286.10 5280.60 0.10
Other Income 179.00 293.60 -39.03 696.60 867.80 -19.73 990.00 565.50 75.07
PBIDT 812.20 808.70 0.43 2990.50 2418.20 23.67 3189.20 2761.70 15.48
Interest 0.30 0.40 -25.00 0.80 0.90 -11.11 1.20 0.90 33.33
PBDT 811.90 808.30 0.45 2989.70 2417.30 23.68 3188.00 2760.80 15.47
Depreciation 67.60 64.70 4.48 201.50 193.50 4.13 256.50 257.70 -0.47
PBT 744.30 743.60 0.09 2788.20 2223.80 25.38 2931.50 2503.10 17.11
TAX 189.80 151.90 24.95 650.00 424.60 53.09 588.90 624.40 -5.69
Deferred Tax -9.30 -16.60 -43.98 -39.00 -61.70 -36.79 -76.90 8.20 -1037.80
PAT 554.50 591.70 -6.29 2138.20 1799.20 18.84 2342.60 1878.70 24.69
Equity 151.90 151.80 0.07 151.90 151.80 0.07 151.80 151.60 0.13
PBIDTM(%) 61.15 61.92 -1.25 61.57 62.98 -2.25 60.33 52.30 15.36
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..